I see BARDA still have their cheque book open for companies developing COVID-19 treatments .... time for Mesoblast to access some of those $ IMO for our additional phase 3 COVID-19 ARDS / ARDS trial
Are you developing a new #COVID19 vaccine or treatment? Request a TechWatch meeting to learn about Project NextGen, a new initiative to accelerate next generation COVID-19 medical countermeasures and to tell our subject matter experts about your product: http://ow.ly/L2fV50O6vTU
I wonder how much sway (if any) Vanderbilt University Medical Centres would have with BARDA ? We are still looking at COVID-19 ARDS as well as all cause ARDS so maybe BARDA will throw us a few sheckles ?
RWE for 2nd MSB COVID-19 ARDS P3 Trial, page-875
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B | |||
| Open | High | Low | Value | Volume |
| $1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 211966 | $1.01 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.02 | 136540 | 9 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| MSB (ASX) Chart |